Improved treatment efficacy of risedronate functionalized chitosan nanoparticles in osteoporosis: formulation development, in vivo, and molecular modelling studies.
Santhosh, Shivalingappa
Improved treatment efficacy of risedronate functionalized chitosan nanoparticles in osteoporosis: formulation development, in vivo, and molecular modelling studies. [electronic resource] - Journal of microencapsulation Jun 2019 - 338-355 p. digital
Publication Type: Journal Article
1464-5246
10.1080/02652048.2019.1631401 doi
Animals
Bone Density--drug effects
Bone Density Conservation Agents--administration & dosage
Chitosan--chemistry
Drug Carriers--chemistry
Female
Nanoparticles--chemistry
Osteoporosis--drug therapy
Rats, Wistar
Risedronic Acid--administration & dosage
Improved treatment efficacy of risedronate functionalized chitosan nanoparticles in osteoporosis: formulation development, in vivo, and molecular modelling studies. [electronic resource] - Journal of microencapsulation Jun 2019 - 338-355 p. digital
Publication Type: Journal Article
1464-5246
10.1080/02652048.2019.1631401 doi
Animals
Bone Density--drug effects
Bone Density Conservation Agents--administration & dosage
Chitosan--chemistry
Drug Carriers--chemistry
Female
Nanoparticles--chemistry
Osteoporosis--drug therapy
Rats, Wistar
Risedronic Acid--administration & dosage